logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12049626 B1

PDFFull Text
Date of Patent:
Jul. 30, 2024

Filed:

Apr. 02, 2020

Gene therapy for neurodegenerative disorders

Applicant:

Prevail Therapeutics, Inc., New York, NY (US);

Inventors:

Asa Abeliovich, New York, NY (US);

Laura Heckman, New York, NY (US);

Herve Rhinn, New York, NY (US);

Assignee:

Prevail Therapeutics, Inc., New York, NY (US);

Attorney:

Wolf, Greenfield & Sacks, P.C.

Primary Examiner:

Kimberly Ballard

Assistant Examiner:

Stacey N MacFarlane

Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 9/00 (2006.01); A61K 48/00 (2006.01); A61P 25/02 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); C12N 9/24 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 9/0019 (2013.01); A61K 9/0085 (2013.01); A61K 48/0075 (2013.01); A61P 25/02 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 9/2402 (2013.01); C12N 15/86 (2013.01); C12Y 302/01045 (2013.01); A61K 48/00 (2013.01); C12N 2310/141 (2013.01); C12N 2310/531 (2013.01); C12N 2710/14043 (2013.01); C12N 2750/14133 (2013.01); C12N 2750/14143 (2013.01); C12N 2770/32022 (2013.01);
Abstract

This Application is a continuation of international patent application serial number PCT/US2018/054223, filed Oct. 3, 2018, which claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application Ser. No. 62/567,303, filed Oct. 3, 2017, entitled 'GENE THERAPIES FOR LYSOSOMAL DISORDERS', and 62/567,305, filed Oct. 3, 2017, entitled “GENE THERAPIES FOR LYSOSOMAL DISORDERS”, the entire contents of each of which are incorporated herein by reference.

Find Patent Forward Citations

Quick Actions:

Abeliovich, Asa. (2024). Gene therapy for neurodegenerative disorders (U.S. Patent No. 12049626). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12049626

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…